Inflammation in background cirrhosis evokes malignant progression in HCC development from HCV-associated liver cirrhosis

被引:20
作者
Tarao, Kazuo [1 ]
Ohkawa, Shinichi [2 ]
Miyagi, Yohei [3 ]
Morinaga, Soichiro [2 ]
Ohshige, Kenji [4 ]
Yamamoto, Naoto [2 ]
Ueno, Makoto [2 ]
Kobayashi, Satoshi [2 ]
Kameda, Ryo [2 ]
Tamai, Setsuo [2 ]
Nakamura, Yoshiyasu [3 ]
Miyakawa, Kaoru [5 ]
Kameda, Yoichi [6 ]
Okudaira, Masahiko [7 ]
机构
[1] Taraos Gastroenterol Clin, Yokohama, Kanagawa, Japan
[2] Kanagawa Canc Ctr Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan
[3] Kanagawa Canc Ctr, Res Inst, Yokohama, Kanagawa 2410815, Japan
[4] Yokohama Natl Univ, Ctr Hlth Serv Sci, Yokohama, Kanagawa 240, Japan
[5] Kinugasa Hosp, Dept Med, Yokosuka, Kanagawa, Japan
[6] Kanagawa Canc Ctr Hosp, Dept Pathol, Yokohama, Kanagawa, Japan
[7] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 228, Japan
关键词
inflammation; hepatocellular carcinoma; promotion; hepatitis C virus-associated liver cirrhosis; stepwise promotion; NF-KAPPA-B; HEPATITIS-C VIRUS; ALANINE AMINOTRANSFERASE LEVELS; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; CELLS; HEPATOCARCINOGENESIS; ADENOCARCINOMA; GLYCYRRHIZIN; MULTICENTER;
D O I
10.3109/00365521.2013.782064
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. It is accepted that inflammation promotes malignant progression in the development of cancers. Whether, this is true for hepatocellular carcinoma (HCC) remains as an open question. We examined the relationship between the inflammatory histology activity index (HAI) in the background liver cirrhosis (LC) and the histological grading of the HCC in the hepatectomized HCC patients with HCV-associated LC. Material and methods. Out of 264 HCC patients who underwent curative hepatic resection, 197 had HCV-associated LC. Among them, 52 patients with a small solitary HCC nodule (<5 cm in diameter) were studied. Inflammation in the background LC was evaluated by modified Knodell's HAI. To evaluate the inflammation, piece meal necrosis, intra lobular cellular degeneration and focal necrosis, portal cellular inflammation (0-4, each) were estimated. The average HAI was calculated. The grade of malignancy of HCC was determined by WHO classification. Results. The average HAI in the 15 patients with moderately differentiated HCC (4.3 +/- 0.8, mean +/- SD) was significantly larger than that in 11 patients with well differentiated HCC (3.5 +/- 0.6, p = 0.036). The HAI in the 24 patients whose HCC nodules contained poorly differentiated HCC (5.2 +/- 1.1) was significantly larger than that in patients with moderately differentiated HCC (p = 0.025). Thus, the HAI order was well differentiated group < moderately differentiated group < poorly differentiated group. Conclusions. Inflammation in the background non-cancerous cirrhotic portion would evoke malignant progression in HCC development from HCV-associated LC.
引用
收藏
页码:729 / 735
页数:7
相关论文
共 49 条
[1]   Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection [J].
Arase, Y ;
Ikeda, K ;
Tsubota, A ;
Suzuki, F ;
Suzuki, Y ;
Saitoh, S ;
Kobayashi, M ;
Akuta, N ;
Someya, T .
INTERVIROLOGY, 2004, 47 (06) :355-361
[2]  
Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO
[3]  
2-B
[4]   Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection [J].
Arase, Yasuji ;
Ikeda, Kenji ;
Suzuki, Fumitaka ;
Suzuki, Yoshiyuki ;
Kobayashi, Masahiro ;
Akuta, Norio ;
Hosaka, Tetsuya ;
Sezaki, Hitomi ;
Yatsuji, Hiromi ;
Kawamura, Yusuke ;
Kobayashi, Mariko ;
Kumada, Hiromitsu .
JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (10) :1485-1490
[5]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[6]   URSODIOL IN THE LONG-TERM TREATMENT OF CHRONIC HEPATITIS - A DOUBLE-BLIND MULTICENTER CLINICAL-TRIAL [J].
BELLENTANI, S ;
PODDA, M ;
TIRIBELLI, C ;
CALLEA, F ;
MARAZZI, C ;
SODDE, M ;
MERLINI, R ;
BATEZZATI, PM ;
CROSIGNANI, A ;
ZUIN, M ;
MANENTI, F .
JOURNAL OF HEPATOLOGY, 1993, 19 (03) :459-464
[7]  
Bosman FT, 2010, WHO CLASSIFICATION T, P211
[8]   NF-κB as a target for pancreatic cancer therapy [J].
Carbone, Carmine ;
Melisi, Davide .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 :S1-S10
[9]   Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J].
Chen, CJ ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Lu, SN ;
Huang, GT ;
Iloeje, UH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :65-73
[10]   Knockout of the Tumor Suppressor Gene Gprc5a in Mice Leads to NF-KB Activation in Airway Epithelium and Promotes Lung Inflammation and Tumorigenesis [J].
Deng, Jiong ;
Fujimoto, Junya ;
Ye, Xiao-Feng ;
Men, Tao-Yan ;
Van Pelt, Carolyn S. ;
Chen, Yu-Long ;
Lin, Xiao-Feng ;
Kadara, Humam ;
Tao, Qingguo ;
Lotan, Dafna ;
Lotan, Reuben .
CANCER PREVENTION RESEARCH, 2010, 3 (04) :424-437